Francesco Morra

1.2k total citations
25 papers, 647 citations indexed

About

Francesco Morra is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Francesco Morra has authored 25 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Francesco Morra's work include PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (6 papers) and Ferroptosis and cancer prognosis (3 papers). Francesco Morra is often cited by papers focused on PARP inhibition in cancer therapy (8 papers), DNA Repair Mechanisms (6 papers) and Ferroptosis and cancer prognosis (3 papers). Francesco Morra collaborates with scholars based in Italy, United States and Germany. Francesco Morra's co-authors include Angela Celetti, Aniello Cerrato, Roberta Visconti, Francesco Merolla, Gennaro Ilardi, Stefania Staibano, Daniela Criscuolo, Virginia Napolitano, Simona Paladino and Roberto Di Monaco and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical Journal and International Journal of Molecular Sciences.

In The Last Decade

Francesco Morra

25 papers receiving 640 citations

Peers

Francesco Morra
Caterina Aversa Italy
Zhi Xiao China
Rujiao Liu China
Roy Ehrnström Sweden
Tisheeka Graham United States
Liping Chung Australia
Kuo-Pao Lai Taiwan
Prasad Kanteti United States
Lixun Chai China
Caterina Aversa Italy
Francesco Morra
Citations per year, relative to Francesco Morra Francesco Morra (= 1×) peers Caterina Aversa

Countries citing papers authored by Francesco Morra

Since Specialization
Citations

This map shows the geographic impact of Francesco Morra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Morra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Morra more than expected).

Fields of papers citing papers by Francesco Morra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Morra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Morra. The network helps show where Francesco Morra may publish in the future.

Co-authorship network of co-authors of Francesco Morra

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Morra. A scholar is included among the top collaborators of Francesco Morra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Morra. Francesco Morra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morra, Francesco, Francesco Merolla, Giovanna Damia, et al.. (2022). The disruption of the CCDC6 – PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma. Journal of Experimental & Clinical Cancer Research. 41(1). 245–245. 9 indexed citations
2.
Miro, Caterina, Annunziata Gaetana Cicatiello, Annarita Nappi, et al.. (2022). Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancer. Cancer Letters. 532. 215581–215581. 38 indexed citations
3.
Criscuolo, Daniela, Francesco Morra, & Angela Celetti. (2022). A xCT role in tumour-associated ferroptosis shed light on novel therapeutic options. SHILAP Revista de lepidopterología. 3(5). 570–581. 5 indexed citations
4.
Capelli, Giulia, Cristina Campi, Quoc Riccardo Bao, et al.. (2022). 18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy. Nuclear Medicine Communications. 43(7). 815–822. 13 indexed citations
5.
Napolitano, Virginia, Daniela Russo, Francesco Morra, et al.. (2021). Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress. Cancers. 13(15). 3822–3822. 5 indexed citations
6.
Morra, Francesco, Francesco Merolla, Federica Zito Marino, et al.. (2021). The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis. Heliyon. 7(11). e08399–e08399. 6 indexed citations
7.
Morra, Francesco, Francesco Merolla, Daniela Russo, et al.. (2019). CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC. Cancers. 11(10). 1582–1582. 14 indexed citations
8.
Morra, Francesco, Francesco Merolla, Gennaro Ilardi, et al.. (2019). Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma. Lung Cancer. 135. 56–65. 13 indexed citations
9.
Criscuolo, Daniela, et al.. (2019). New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment. Journal of Experimental & Clinical Cancer Research. 38(1). 91–91. 48 indexed citations
10.
Morra, Francesco, Francesco Merolla, Daniela Criscuolo, et al.. (2019). CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 90–90. 29 indexed citations
11.
Criscuolo, Daniela, et al.. (2019). Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors. International Journal of Molecular Sciences. 20(12). 3100–3100. 32 indexed citations
12.
Visconti, Roberta, et al.. (2017). The between Now and Then of Lung Cancer Chemotherapy and Immunotherapy. International Journal of Molecular Sciences. 18(7). 1374–1374. 46 indexed citations
13.
Morra, Francesco, Francesco Merolla, Virginia Napolitano, et al.. (2017). The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells. Oncotarget. 8(19). 31815–31829. 54 indexed citations
14.
Cerrato, Aniello, Francesco Merolla, Francesco Morra, & Angela Celetti. (2017). CCDC6: the identity of a protein known to be partner in fusion. International Journal of Cancer. 142(7). 1300–1308. 27 indexed citations
15.
Cerrato, Aniello, Francesco Morra, & Angela Celetti. (2016). Use of poly ADP-ribose polymerase [PARP] inhibitors in cancer cells bearing DDR defects: the rationale for their inclusion in the clinic. Journal of Experimental & Clinical Cancer Research. 35(1). 179–179. 94 indexed citations
16.
Malapelle, Umberto, Francesco Morra, Gennaro Ilardi, et al.. (2016). USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs. Lung Cancer. 107. 41–49. 54 indexed citations
17.
Morra, Francesco, Chiara Luise, Francesco Merolla, et al.. (2015). FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLC. Oncotarget. 6(14). 12697–12709. 41 indexed citations
18.
Morra, Francesco, Chiara Luise, Roberta Visconti, et al.. (2014). New therapeutic perspectives in CCDC6 deficient lung cancer cells. International Journal of Cancer. 136(9). 2146–2157. 40 indexed citations
19.
Rubini, Alessandro, et al.. (2013). The effect of body cooling on respiratory system mechanics and hysteresis in rats. Respiratory Physiology & Neurobiology. 189(1). 52–58. 11 indexed citations
20.
Morra, Francesco, et al.. (1995). Effects of keratinocyte-secreted soluble factors on spreading, number of dendrites and cell-cell contacts of human epidermal melanocytes and dermal fibroblasts: a quantitative analysis.. PubMed. 4(4). 143–55. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caterina Aversa Breakdown of academic impact, for papers by Zhi Xiao Breakdown of academic impact, for papers by Rujiao Liu Breakdown of academic impact, for papers by Roy Ehrnström Breakdown of academic impact, for papers by Tisheeka Graham Breakdown of academic impact, for papers by Liping Chung Breakdown of academic impact, for papers by Kuo-Pao Lai Breakdown of academic impact, for papers by Prasad Kanteti Breakdown of academic impact, for papers by Lixun Chai
Rankless by CCL
2026